Weight-Loss Injections Ozempic & Zepbound Face Over 2,000 Lawsuits As Patients Allege Vision Loss, Gallbladder Disease & Vomiting

Weight-Loss Injections Ozempic & Zepbound Face Over 2,000 Lawsuits As Patients Allege Vision Loss, Gallbladder Disease & Vomiting

More than 2,000 lawsuits have been filed in the United States against the makers of Ozempic and Zepbound, with patients alleging life-threatening side effects linked to the popular diabetes and weight-loss drugs.

The consolidated litigation, based in Pennsylvania federal court, is now in the discovery phase. In February 2024, the Judicial Panel on Multidistrict Litigation grouped the cases into MDL No. 3094, and by August 2025 legal trackers reported over 2,000 active cases.

Plaintiffs claim Novo Nordisk and Eli Lilly failed to adequately warn about risks. Central to the lawsuits are allegations that patients developed gastroparesis, or stomach paralysis. Other reported side effects include intestinal obstruction, ileus, vomiting, gallbladder disease, and vision loss.

Attention has increasingly turned to Zepbound, approved in 2023, with the FDA updating its label in 2025 to include ileus. Both companies deny wrongdoing, maintaining that product information complies with federal standards and risks are clearly outlined.

What are your thoughts on these shocking claims?